(Q44575041)

4 December 2017

title

A comparative study of the in vitro antioxidant activity of statins (English)

1 reference

4 December 2017

3

1 reference

4 December 2017

4

Ele Ferrannini

1 reference

4 December 2017

Ferdinando Franzoni

1

1 reference

4 December 2017

Alfredo Quiñones-Galvan

series ordinal

2

1 reference

4 December 2017

Fabio Galetta

series ordinal

5

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

International Journal of Cardiology

4 December 2017

published in

1 reference

4 December 2017

volume

90

1 reference

4 December 2017

issue

2-3

1 reference

4 December 2017

page(s)

317-321

1 reference

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900577-6

7 January 2021

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900577-6

7 January 2021

Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900577-6

7 January 2021

Statins do more than just lower cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900577-6

7 January 2021

Interactions of platelets, macrophages, and lipoproteins in hypercholesterolemia: antiatherogenic effects of HMG-CoA reductase inhibitor therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900577-6

7 January 2021

Lovastatin inhibits low-density lipoprotein oxidation and alters its fluidity and uptake by macrophages: in vitro and in vivo studies

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900577-6

7 January 2021

Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900577-6

7 January 2021

Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900577-6

7 January 2021

HMG-CoA reductase inhibition: anti-inflammatory effects beyond lipid lowering?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900577-6

7 January 2021

An in vitro study of the hydroxyl radical scavenging property of fluvastatin, and HMG-CoA reductase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900577-6

7 January 2021

Atorvastatin and gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900577-6

7 January 2021

Short-term treatment with low-dose pravastatin attenuates oxidative susceptibility of low-density lipoprotein in hypercholesterolemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900577-6

7 January 2021

Simvastatin decreases aldehyde production derived from lipoprotein oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900577-6

7 January 2021

Reactive oxygen-mediated protein oxidation in aging and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900577-6

7 January 2021

Targets of oxidative stress in cardiovascular system

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900577-6

7 January 2021

Mitochondria, oxidative stress and aging.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900577-6

7 January 2021

Reperfusion injury: experimental evidence and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900577-6

7 January 2021

Oxyradicals and DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900577-6

7 January 2021

A Rapid Gas Chromatographic Assay for Determining Oxyradical Scavenging Capacity of Antioxidants and Biological Fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900577-6

7 January 2021

Quantification of Total Oxidant Scavenging Capacity of Antioxidants for Peroxynitrite, Peroxyl Radicals, and Hydroxyl Radicals

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900577-6

7 January 2021

The ambivalence of vitamin E in atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900577-6

7 January 2021

Intracellular antioxidants: from chemical to biochemical mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900577-6

7 January 2021

Probucol as an antioxidant and antiatherogenic drug

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900577-6

7 January 2021

10.1016/S0167-5273(02)00577-6

Identifiers

DOI

1 reference

4 December 2017

1 reference